| RS1566972371 |
TRIP4
|
Health Risk |
Pathogenic |
— |
| RS1566973583 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1566974586 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1566975090 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1566975163 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1566975448 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS1566975668 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1566977567 |
DUOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS1566978577 |
DUOX2
|
Health Risk |
Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS1566979450 |
COA8
|
Health Risk |
Pathogenic |
— |
| RS1566980722 |
COA8
|
Health Risk |
Pathogenic |
— |
| RS1566982116 |
IREB2
|
Health Risk |
Likely pathogenic |
Neurodegeneration, early-onset |
| RS1566983844 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS1566984441 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1566984719 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1566984937 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1566988788 |
EIF2AK4
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS1566989338 |
CDAN1
|
Health Risk |
Pathogenic |
— |
| RS1566991387 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1566992093 |
TCF12
|
Health Risk |
Likely pathogenic |
Coronal craniosynostosis, Coronal craniosynostosis |
| RS1566993126 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, See cases |
| RS1566993302 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1566996726 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures, Charcot-Marie-Tooth disease axonal type 2O |
| RS1566997890 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1566999047 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
— |
| RS1566999423 |
SMAD3
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1566999458 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial aortopathy, Familial thoracic aortic aneurysm and aortic dissection |
| RS1566999601 |
SMAD3
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1566999610 |
SMAD3
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1566999621 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1567002059 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1567002115 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1567003613 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1567004102 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS1567005489 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1567005557 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease axonal type 2O |
| RS1567006266 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2O |
| RS1567010427 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
— |
| RS1567012503 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS1567013693 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS1567014543 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1567017307 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2O |
| RS1567018763 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1567019064 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1567019327 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1567020949 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Intellectual disability |
| RS1567021756 |
WDR73
|
Health Risk |
Likely pathogenic |
— |
| RS1567024512 |
CEP152
|
Health Risk |
Likely pathogenic |
Microcephaly 9, primary |
| RS1567027297 |
AAGAB
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma, punctate type 1A |
| RS1567027610 |
AAGAB
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma, punctate type 1A |
| RS1567028689 |
CEP152
|
Health Risk |
Likely pathogenic |
Microcephaly 9, primary |
| RS1567035597 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567035745 |
BLM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1567036566 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1567036579 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567036793 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1567037561 |
AAGAB
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma, punctate type 1A |
| RS1567038003 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1567040469 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567040910 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567043467 |
CCDC88C
|
Health Risk |
Pathogenic |
Hydrocephalus, nonsyndromic |
| RS1567045130 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1567045235 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567045531 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1567047642 |
CIB2
|
Health Risk |
Pathogenic |
Usher syndrome type 1J, Usher syndrome type 1J |
| RS1567049981 |
CIB2
|
Health Risk |
Pathogenic |
— |
| RS1567050773 |
CYP11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1567052156 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567052178 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1567052324 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567053134 |
CYP11A1
|
Health Risk |
Pathogenic |
Congenital adrenal insufficiency with 46, XY sex reversal OR 46 |
| RS1567053170 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1567057019 |
KIF7
|
Health Risk |
Likely pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS1567060070 |
KIF7
|
Health Risk |
Likely pathogenic |
— |
| RS1567060305 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567062835 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567063125 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567065650 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1567066891 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1567067864 |
KIF7
|
Health Risk |
Pathogenic/Likely pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS1567068388 |
CIB1
|
Health Risk |
risk factor |
Epidermodysplasia verruciformis, susceptibility to |
| RS1567069906 |
CIB1
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, susceptibility to |
| RS1567075176 |
PLIN1
|
Health Risk |
Pathogenic |
PLIN1-related familial partial lipodystrophy, PLIN1-related familial partial lipodystrophy |
| RS1567075667 |
PLIN1
|
Health Risk |
Pathogenic |
PLIN1-related familial partial lipodystrophy, PLIN1-related familial partial lipodystrophy |
| RS1567084743 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1567089714 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1567092020 |
SMAD6
|
Health Risk |
Pathogenic |
Aortic valve disease 1, Aortic valve disease 1 |
| RS1567092048 |
SMAD6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1567092071 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 1, Aortic valve disease 2 |
| RS1567093598 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS1567093760 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1567094168 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiomyopathy |
| RS1567094183 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1567094729 |
HERC1
|
Health Risk |
Likely pathogenic |
— |
| RS1567095153 |
CLN6
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS1567095321 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS1567106381 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS1567106459 |
CHSY1
|
Health Risk |
Pathogenic |
Temtamy preaxial brachydactyly syndrome, Temtamy preaxial brachydactyly syndrome |
| RS1567108397 |
GPHN
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS1567112402 |
CHSY1
|
Health Risk |
Pathogenic |
Temtamy preaxial brachydactyly syndrome, Temtamy preaxial brachydactyly syndrome |